Deignan Charles A.

Chief Financial Officer

1 company

Strong

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+8.2%

Avg 12M Return

+43.6%

Deignan Charles A. is a Chief Financial Officer at Clearside Biomedical, Inc.. Recent SEC Form 4 filings include 4 buys and 6 sells.

Estimated insider holdings value: $123K based on current market prices.

Holdings by Company

CLSDQJan 19, 2024

Current Shares384.7K

Value$123.1K

Net Activity-37,495

Bought: 19.0KSold: 56.5K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 19, 2024	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	12,900	$1.28	$16,512.00	-3.2%	+2.3%	-27.9%
Jan 19, 2023	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	14,030	$1.50	$21,045.00	-3.7%	-21.8%	-12.2%
Jan 19, 2022	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	8,833	$2.09	$18,460.97	-2.5%	-7.1%	-30.3%
Sep 21, 2021	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	2,800	$6.41	$17,948.00	-0.9%	-55.5%	-82.3%
Jun 21, 2021	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	2,938	$4.37	$12,839.06	-0.9%	+40.8%	-65.4%
Jun 1, 2020	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Sell	14,992	$1.88	$28,184.96	-6.4%	-	-
Nov 12, 2019	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Buy	7,500	$1.14	$8,550.00	+3.8%	-	-
Mar 15, 2019	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Buy	10,000	$1.36	$13,600.00	+15.1%	-	-
Mar 23, 2018	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Buy	500	$11.79	$5,895.00	+0.8%	-	-
Aug 14, 2017	CLSDQ Clearside Biomedical, Inc.	Chief Financial Officer	Buy	1,000	$7.07	$7,065.00	+1.6%	-	-